Matches in SemOpenAlex for { <https://semopenalex.org/work/W78865009> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W78865009 endingPage "536" @default.
- W78865009 startingPage "533" @default.
- W78865009 abstract "The follow-up of thyroid cancer is based on the detection of residual and recurrent thyroid carcinoma. This is traditionally done by means of measurements of serum thyroglobulin (Tg) combined with various imaging techniques ( 131 I-whole body scan, ultrasound and other modalities). Tg serum levels and the uptake of 131 I on a whole body scan (WBS) depend on TSH stimulation, which in thyroidectomized patients can be obtained either by withdrawal of thyroid hormone treatment (thyroxine) or by administration of exogenous TSH. At present exogenous human TSH is obtained by means of recombinant DNA technology, (recombinant human TSH (rhTSH), Thyrogen™). Even if the administration of rhTSH and withdrawal of thyroid hormone are not completely equivalent, the use of rhTSH has already entered the clinical routine (rhTSH Tg test and rhTSH WBS) because with rhTSH the morbidity and discomfort associated with the withdrawal of thyroid hormone can be avoided. At a recent International Consensus Conference on the follow-up of differentiated thyroid carcinoma it was proposed to carry out only Tg measurement after rhTSH stimulation; moreover, it was stated that 131 I whole body scan has to be discouraged in patients submitted to radical surgery and radioiodine ablation with no clinical evidence of residual tumor and with undetectable levels of Tg during hormonal suppression of TSH. Similar strategies in this respect tend to eliminate the 131 I WBS and propose only the rhTSH Tg test combined with head and neck ultrasound (US). This is still a matter of debate, also because it is not valid for all risk groups and not all patients undergo the same clinical management (radical surgery or not, thyroid ablation with 131 I or not). However, the availability of rhTSH will definitely change the management of papillary and follicular thyroid carcinoma, also with regard to iodine treatment. In fact, rhTSH can be used during radioiodine treatment to enhance the 131 I uptake by the cancer cells in particular groups of patients. Patients who could benefit from this approach can be divided into three subgroups: 1) patients in whom thyroxine withdrawal may be dangerous because of the effects of long-term TSH stimulation on the tumor mass (brain metastases, vertebral metastases, presence of neurological signs, heart diseases); 2) patients affected by tumors with marked biological aggressiveness and a low iodine uptake (variants of follicular carcinoma, insular carcinoma, tall and columnar cell variants of papillary thyroid carcinoma, Hürthle cell carcinoma); 3) patients with hypothalamic-pituitary alterations. The potential efficiency of rhTSH in radiometabolic treatment is an important issue that has been studied in a limited number of patients, but is worthy of further investigations in large perspective. A recent clinical prospective trial has been proposed by the Thyroid Cancer Study Group of the Istituto Nazionale Tumori and is now ongoing." @default.
- W78865009 created "2016-06-24" @default.
- W78865009 creator A5026845792 @default.
- W78865009 creator A5031924931 @default.
- W78865009 creator A5054372316 @default.
- W78865009 creator A5063791104 @default.
- W78865009 creator A5088974025 @default.
- W78865009 date "2003-09-01" @default.
- W78865009 modified "2023-09-25" @default.
- W78865009 title "Recombinant Human Thyrotropin (rhTSH) in the Follow-Up and Treatment of Patients with Thyroid Cancer" @default.
- W78865009 cites W1966715409 @default.
- W78865009 cites W1968467130 @default.
- W78865009 cites W1978632252 @default.
- W78865009 cites W1980454762 @default.
- W78865009 cites W1987229242 @default.
- W78865009 cites W1988314055 @default.
- W78865009 cites W1990804058 @default.
- W78865009 cites W2005069145 @default.
- W78865009 cites W2018556609 @default.
- W78865009 cites W2018661446 @default.
- W78865009 cites W2020039644 @default.
- W78865009 cites W2025756798 @default.
- W78865009 cites W2029872319 @default.
- W78865009 cites W2069445405 @default.
- W78865009 cites W2069492422 @default.
- W78865009 cites W2080648287 @default.
- W78865009 cites W2091291633 @default.
- W78865009 cites W2103912940 @default.
- W78865009 cites W2124524123 @default.
- W78865009 cites W2126089201 @default.
- W78865009 cites W2134480384 @default.
- W78865009 cites W2167632483 @default.
- W78865009 cites W2331220651 @default.
- W78865009 cites W2416632497 @default.
- W78865009 doi "https://doi.org/10.1177/030089160308900515" @default.
- W78865009 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14870779" @default.
- W78865009 hasPublicationYear "2003" @default.
- W78865009 type Work @default.
- W78865009 sameAs 78865009 @default.
- W78865009 citedByCount "14" @default.
- W78865009 countsByYear W788650092014 @default.
- W78865009 countsByYear W788650092015 @default.
- W78865009 countsByYear W788650092021 @default.
- W78865009 crossrefType "journal-article" @default.
- W78865009 hasAuthorship W78865009A5026845792 @default.
- W78865009 hasAuthorship W78865009A5031924931 @default.
- W78865009 hasAuthorship W78865009A5054372316 @default.
- W78865009 hasAuthorship W78865009A5063791104 @default.
- W78865009 hasAuthorship W78865009A5088974025 @default.
- W78865009 hasConcept C126322002 @default.
- W78865009 hasConcept C126894567 @default.
- W78865009 hasConcept C134018914 @default.
- W78865009 hasConcept C2778835679 @default.
- W78865009 hasConcept C2779761222 @default.
- W78865009 hasConcept C2993294228 @default.
- W78865009 hasConcept C526584372 @default.
- W78865009 hasConcept C71315377 @default.
- W78865009 hasConcept C71924100 @default.
- W78865009 hasConceptScore W78865009C126322002 @default.
- W78865009 hasConceptScore W78865009C126894567 @default.
- W78865009 hasConceptScore W78865009C134018914 @default.
- W78865009 hasConceptScore W78865009C2778835679 @default.
- W78865009 hasConceptScore W78865009C2779761222 @default.
- W78865009 hasConceptScore W78865009C2993294228 @default.
- W78865009 hasConceptScore W78865009C526584372 @default.
- W78865009 hasConceptScore W78865009C71315377 @default.
- W78865009 hasConceptScore W78865009C71924100 @default.
- W78865009 hasIssue "5" @default.
- W78865009 hasLocation W788650091 @default.
- W78865009 hasLocation W788650092 @default.
- W78865009 hasOpenAccess W78865009 @default.
- W78865009 hasPrimaryLocation W788650091 @default.
- W78865009 hasRelatedWork W1972113515 @default.
- W78865009 hasRelatedWork W2010645160 @default.
- W78865009 hasRelatedWork W2026117978 @default.
- W78865009 hasRelatedWork W2027938488 @default.
- W78865009 hasRelatedWork W2074577918 @default.
- W78865009 hasRelatedWork W2076322483 @default.
- W78865009 hasRelatedWork W2133230490 @default.
- W78865009 hasRelatedWork W2155312245 @default.
- W78865009 hasRelatedWork W2165389221 @default.
- W78865009 hasRelatedWork W2095364283 @default.
- W78865009 hasVolume "89" @default.
- W78865009 isParatext "false" @default.
- W78865009 isRetracted "false" @default.
- W78865009 magId "78865009" @default.
- W78865009 workType "article" @default.